These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2511112)

  • 21. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic colony formation after allogeneic bone marrow transplantation: enhancement by cyclosporin A and anti-gamma-(immune) interferon antiserum in vitro.
    Raghavachar A; Frickhofen N; Arnold R; Schmeiser T; Porzsolt F; Heimpel H
    Exp Hematol; 1986 Aug; 14(7):621-5. PubMed ID: 3089830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
    Weekx SF; Van Bockstaele DR; Plum J; Moulijn A; Rodrigus I; Lardon F; De Smedt M; Nijs G; Lenjou M; Loquet P; Berneman ZN; Snoeck HW
    Exp Hematol; 1998 Oct; 26(11):1034-42. PubMed ID: 9766443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF; Goldwasser E; Fitch FW
    J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
    Tauro S; Hepburn MD; Bowen DT; Pippard MJ
    Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
    Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant gamma-interferon induces in vitro monocytic differentiation of blast cells from patients with acute nonlymphocytic leukemia and myelodysplastic syndromes.
    Carlo Stella C; Cazzola M; Ganser A; Bergamaschi G; Meloni F; Pedrazzoli P; Bernasconi P; Invernizzi R; Hoelzer D; Ascari E
    Leukemia; 1988 Jan; 2(1):55-9. PubMed ID: 3123808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effects of stem cell factor and interleukin 6 or interleukin 11 on the expansion of murine hematopoietic progenitors in liquid suspension culture.
    Ariyama Y; Misawa S; Sonoda Y
    Stem Cells; 1995 Jul; 13(4):404-13. PubMed ID: 7549899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation by retinoic acid of the growth of bone marrow cell progenitors from patients with myelodysplastic syndrome.
    De Francesco A; Sanavio F; Stacchini A; Piacibello W; Quaglino D; Aglietta M
    Haematologica; 1989; 74(1):25-8. PubMed ID: 2498179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
    Murphy M; Perussia B; Trinchieri G
    Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
    Broxmeyer HE; Cooper S; Rubin BY; Taylor MW
    J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of hematopoietic precursor cells to hematopoietic growth factors in the myelodysplastic syndromes.
    Thomas X; Campos L; Bonnier S; Troncy J; Guyotat D; Fière D
    Nouv Rev Fr Hematol (1978); 1990; 32(5):345-7. PubMed ID: 2099409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of hematopoiesis by sera from patients with myelodysplastic syndromes].
    Ding R; Liu H; Xu R
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):515-7. PubMed ID: 11721395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocytes enhance gamma-interferon-induced inhibition of myeloid progenitor cell growth through secretion of tumor necrosis factor.
    Cannistra SA; Groshek P; Griffin JD
    Exp Hematol; 1988 Nov; 16(10):865-70. PubMed ID: 3139436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
    Sloand EM; Young NS; Sato T; Kim S; Maciejewski JP
    Exp Hematol; 1998 Oct; 26(11):1093-9. PubMed ID: 9766451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of hematopoietic growth factors on extensive apoptosis of myelodysplastic hematopoietic cells and its clinical significance].
    Cao Z; Li R; Li Q
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):27-30. PubMed ID: 10921099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
    Taniguchi S; Dai CH; Krantz SB
    Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.